-
Entity
-
Individual
-
Location
-
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
-
Summary
-
The estimated net worth of Thomas Malley is at least $16.7M dollars as of June 7, 2024. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $15.1M. Thomas Malley is the Director of Kura Oncology, Inc. and owns shares of Kura Oncology, Inc. (KURA) stock worth about $1.6M.